Atlantic International Corp.
NASDAQ:ATLNMedical - Diagnostics & Research
-$0.10 today
- Market cap
- $73.17M
- Beta
- 0.71
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.08
Volume 18.56M
Average 0.44M
ATLN Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Atlantic International Corp.NASDAQ: ATLN
Stock-Based Compensation · Q4 FY2025 · quarter ended Dec 2025
Stock-based compensation declines year over year
Q4 FY2025 stock-based compensation of $17.12M fell 57.6% year over year, behind the -20.0% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 155.2% from the prior quarter. Over 3 fiscal years it compounded at +420.1% a year.
Context
- Stock-based compensation amounted to 8.3% of revenue in FY2025, down 1.9 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -57.6% toward the trailing-twelve-month pace of -20.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 36.14M USD
- Year-over-year change
- -20.0%
- 4-year CAGR
- +222.5%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 36.14M | -20.0% |
| FY2024 | 2024-12-31 | 45.2M | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 256.9K | -23.1% |
| FY2021 | 2021-12-31 | 333.98K | — |
Stock-Based Compensation vs competitors
How ATLN compares with its peers on the latest reported figures
- ATLN's LTM Dec 2025 stock-based compensation of $36.14M is the largest of the 8 companies compared; the peer median is $5.4M.
- Its year-over-year change of -20.0% is the 5th highest of 8, against a peer median of -15.1%.
- Stock-based compensation amounts to 8.3% of revenue for ATLN, versus a peer median of 123.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ATLNAtlantic International Corp. | LTM Dec 2025 | $36.14M | -20.0% | +420.1% | 8.3% |
| LTM Mar 2026 | $10.03M | -22.0% | +30.6% | — | |
| LTM Mar 2026 | $7.62M | -49.8% | -20.2% | — | |
| LTM Mar 2026 | $6.14M | +9.4% | -6.2% | 344.3% | |
| LTM Mar 2026 | $5.4M | -5.3% | -7.8% | 3.6% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $4.48M | -15.1% | +38.4% | 241.9% |
IMDXInsight Molecular Diagnostics Inc. | LTM Mar 2026 | $2.4M | +50.7% | -39.5% | 123.1% |
| LTM Mar 2026 | $141K | -98.0% | — | 0.1% | |
| Peer median (excluding ATLN) | $5.4M | -15.1% | -7.0% | 123.1% | |
Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (3.7M) | (4.09M) | (15.25M) | (135.48M) | (59.43M) |
| Depreciation & Amortization | 86.44K | 87.94K | 5.04M | 4.99M | 210.5K |
| Deferred Income Tax | 0 | 0 | (5.14M) | 5.24M | 0 |
| Stock-Based Compensation | 333.98K | 256.9K | 0 | 45.2M | 36.14M |
| Change in Working Capital | 119.96K | (155.38K) | 204.34K | 15.95M | 10.22M |
| Accounts Receivables | 73.85K | (15.54K) | (384.28K) | (9.92M) | 2.41M |
| Inventory | (21.14K) | (20.71K) | 0 | 0 | 0 |
| Accounts Payables | 9.52K | (248.93K) | 631.86K | 1.23M | 3.08M |
| Other Working Capital | 57.73K | 129.79K | (43.24K) | 24.64M | 4.72M |
| Other Non-Cash Items | 1.17M | 242.81K | 6.07M | 58.11M | 8.47M |
| Operating Cash Flow | (1.99M) | (3.66M) | (9.08M) | (5.99M) | (4.4M) |
| Capital Expenditures | (14.47K) | (40.02K) | (73.71K) | (73.46K) | (66.77K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (5.98M) | (4.01M) | (2.8M) | 0 | 0 |
| Sales of Investments | 0 | 5.88M | 6.92M | 0 | 0 |
| Other Investing Activities | 0 | 0 | (4.12M) | 0 | 0 |
| Investing Cash Flow | (5.99M) | 1.83M | (73.71K) | (73.46K) | (66.77K) |
| Debt Repayment | (187.89K) | 0 | 8.83M | (962.48K) | 3.87M |
| Common Stock Issued | 13.81M | 0 | 1.8M | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.63M) | 0 | (1.84M) | 6.35M | 0 |
| Financing Cash Flow | 12M | 0 | 8.79M | 5.38M | 3.87M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 4.02M | (1.83M) | (363.23K) | (674.25K) | (597.54K) |
| Free Cash Flow | (2M) | (3.7M) | (9.16M) | (6.06M) | (4.46M) |
Atlantic International Corp.
NASDAQ:ATLN
Intrinsic Alpha fair value
Locked
Current Price
$0.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.